Aestas Pharma Inc. is dedicated to the development of novel diagnostic imaging and therapeutic agents to enable the EARLY detection and REVERSAL of severely debilitating Alzheimer’s diseases (AD) and Parkinson’s disease (PD). In marked contrast to competitor's approaches, including development stage diagnostic agents and drugs, Aestas is focused on targeting the very earliest stages of AD and PD, when clinical signs are not yet pronounced.
| Website | http://www.aestaspharma.com/ |
| Revenue | $4 million |
| Employees | 2 (0 on RocketReach) |
| Founded | 2015 |
| Address | 142 Covington PL, Lewisville, North Carolina 27023, US |
| Phone | (610) 202-5389 |
| Technologies |
JavaScript
,
HTML
,
PHP
+15 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing, Manufacturing General, Manufacturing |
| Keywords | Neurodegenerative Disease Treatment, Novel Drug Development, Pharmaceutical Research, Biopharmaceutical Development, Drug Discovery Platform, Advanced Therapeutics, Imaging Biomarkers, Therapeutic Agents, Precision Medicine, Dementia Treatment, Neurological Disorders, Pharmaceutical Innovation |
| Competitors | Roche, Pfizer, Amgen, Bristol Myers Squibb, Novartis, Gilead Sciences, Johnson & Johnson, Merck AH, Receptos, a wholly-owned subsidiary of Celgene, Lilly India +39 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular Aestas Pharma Inc. employee's phone or email?
Aestas Pharma Inc. Questions
The Aestas Pharma Inc. annual revenue was $4 million in 2026.
Aestas Pharma Inc. is based in Lewisville, North Carolina.
The NAICS codes for Aestas Pharma Inc. are [3254, 32541, 32, 325].
The SIC codes for Aestas Pharma Inc. are [28, 283].
Related Companies
